Neutralization, Immunofluorescence and Complement Fixation Tests in Identification of Antibody to a Herpesvirus Type 2-Induced, Tumor-Specific Antigen in Sera from Squamous Cervical Carcinoma

2015 ◽  
pp. 165-181 ◽  
Author(s):  
L. Aurelian ◽  
J. D. Strandberg ◽  
R. L. Marcus
Keyword(s):  
Cervical Carcinoma ◽  
Complement Fixation ◽  
Specific Antigen ◽  
Herpesvirus Type ◽  
Squamous Cervical Carcinoma ◽  
Tumor Specific Antigen

HERPESVIRUS TYPE 2 INDUCED, TUMOR-SPECIFIC ANTIGEN IN CERVICAL CARCINOMA1

1973 ◽  
Vol 98 (1) ◽  
pp. 1-9 ◽  
Author(s):  
LAURE AURELIAN ◽  
HUGH J. DAVIS ◽  
CONRAD G. JULIAN
Keyword(s):  
Specific Antigen ◽  
Herpesvirus Type ◽  
Tumor Specific Antigen

HERPESVIRUS TYPE 2 AND CERVICAL CARCINOMA

1970 ◽  
Vol 174 (2 Unusual Isola) ◽  
pp. 993-998 ◽  
Author(s):  
Joseph L. Melnick ◽  
William E. Rawls
Keyword(s):  
Cervical Carcinoma ◽  
Herpesvirus Type

SEROEPIDEMIOLOGIC STUDIES OF HERPESVIRUS TYPE 2 AND CARCINOMA OF THE CERVIX. IV. DYSPLASIA AND CARCINOMA IN SITU1

1973 ◽  
Vol 98 (2) ◽  
pp. 77-87 ◽  
Author(s):  
ERVIN ADAM ◽  
RAYMOND H. KAUFMAN ◽  
JOSEPH L. MELNICK ◽  
ALLAN H. LEVY ◽  
WILLIAM E. RAWLS
Keyword(s):  
Herpesvirus Type ◽  
Seroepidemiologic Studies

Herpesvirus Type 2: Study of Semen in Male Subjects with Recurrent Infections

1978 ◽  
Vol 120 (4) ◽  
pp. 449-451 ◽  
Author(s):  
Francis A. Deture ◽  
David M. Drylie ◽  
Herbert E. Kaufman ◽  
Ysolina M. Centifanto
Keyword(s):  
Recurrent Infections ◽  
Herpesvirus Type ◽  
Male Subjects

scholarly journals Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma

2010 ◽  
Vol 2010 ◽  
pp. 1-3 ◽  
Author(s):  
Talvensaari-Mattila Anne ◽  
Turpeenniemi-Hujanen Taina
Keyword(s):  
Cervical Carcinoma ◽  
Matrix Metalloproteinase 2 ◽  
Healthy Controls ◽  
Matrix Degradation ◽  
Serum Samples ◽  
Study Population ◽  
The Mean ◽  
Natural Tissue ◽  
Squamous Cervical Carcinoma

Background. The role of matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in matrix degradation and metastasis has been described in various tumors. Their action is inhibited by their natural tissue inhibitor molecules TIMP-1 and -2.Methods. The study population consisted of 12 squamous cervical carcinoma patients and 27 healthy volunteer control patients. MMP-9, MMP-2-TIMP-2 complex, TIMP-1, and TIMP-2 were analyzed from serum samples using enzyme-linked immunoassay (ELISA).Results. The mean levels of serum TIMP-2 and of MMP-2-TIMP-2 complex were higher in healthy controls compared to patients with a malignant tumor. Serum TIMP-2 values decreased significantly from healthy controls (median 323 g/l, range 305–342 g/l) to malignant (median 136 g/l, range 120–151 g/l) squamous cervical carcinoma patients . Also, serum proMMP2-TIMP2 complex values decreased from control patients to squamous cervical carcinoma patients .Conclusion. This paper shows that the levels of circulating TIMP-2 and that of MMP-2-TIMP-2 complex are lower in squamous cervical carcinoma patients than in healthy women.

scholarly journals Characterization of A Tumor-Specific Antigen Expressing on Chang Hepatoma Ascites Cells.

2000 ◽  
Vol 33 (5) ◽  
pp. 367-375
Author(s):  
Sheng-Chieh Lin ◽  
Steve R. Roffler ◽  
Tang-Lu Cheng ◽  
Kuo-Ting Chang ◽  
Jeffrey P. Chang ◽  
...  
Keyword(s):  
Specific Antigen ◽  
Tumor Specific Antigen
Sign in / Sign up

Export Citation Format

Share Document